Results 201 to 210 of about 8,240,144 (350)

Japanese reproductive medicine under health insurance: A brief review and prospects. [PDF]

Reprod Med Biol
Iwase A.
europepmc   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

An evidence map on traditional medicine across health outcomes. [PDF]

Integr Med Res
Ang L, Song E, Jong MC, Alræk T, Wider B, Choi TY, Jun JH, Lee B, Choi Y, Lee HW, Yang C, Yim MH, Yamashita H, Ji Z, Hu H, Zhang J, Liu J, Chen Y, Qin Y, Lu L, Qu F, Hansen OM, Kwon CY, Leem J, Lee H, Kim TH, Kim KH, Park S, Lee YS, Jang S, Won J, Choi J, Lee J, Kim SY, Lee MS.   +34 more
europepmc   +1 more source

Corrigendum to "Integrative Medicine and Health Inspires Global Advances". [PDF]

Glob Adv Integr Med Health, 2023
europepmc   +1 more source

No Boundaries for Toxicology in Clinical Medicine: One Health, One Society and One Planet for All of Us. [PDF]

J Clin Med, 2023
Dinis-Oliveira RJ.
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Care of Diabetes and the Sacrifice of Evidence-Based Medicine and Health Equity. [PDF]

J Gen Intern Med
Goldberg D.
europepmc   +1 more source

Opinion research among Russian Physicians on the application of technologies using artificial intelligence in the field of medicine and health care. [PDF]

BMC Health Serv Res, 2023
Orlova IA, Akopyan ZA, Plisyuk AG, Tarasova EV, Borisov EN, Dolgushin GO, Khvatova EI, Grigoryan MA, Gabbasova LA, Kamalov AA.   +9 more
europepmc   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source